Abstract In 2020, the World Health Organization (WHO) launched a strategy to eliminate
cervical cancer as a public health problem. To support the strategy, the WHO published …

Low-cost optical imaging technologies have the potential to reduce inequalities in health
care by improving the detection of precancer or early cancer and enabling more effective …

We review developments in molecular triaging options for women who test positive for high-
risk human papillomavirus (hrHPV) on self-collected samples in the context of cervical …

To support a strategy to eliminate cervical cancer as a public health problem, the World
Health Organisation (WHO) reviewed its guidelines for screening and treatment of cervical …

Objective Guidelines for effective triage following positive primary high‐risk human
papillomavirus (HPV) screening in low‐and middle‐income countries with high human …

Objective To evaluate the performance of visual inspection with acetic acid (VIA) testing,
visual inspection with Lugol's iodine (VILI), primary HPV testing, and conventional Pap …

Background Low-and middle-income countries (LMICs) account for nearly 85% of the global
cervical cancer burden, yet have the least access to high-performance screening …

In response to calls by the World Health Organization for cervical precancer screening
services in low-resource settings to lean toward HPV DNA testing, a number of testing …

Evidence supports the use of primary HPV testing to accelerate the global elimination of
cervical cancer, but such recommendations must be viewed in the context of the fragile …

Background: To report quantitative and qualitative results on cervical cancer human
papillomavirus (HPV)-based screening and treatment algorithms, with/out triage with visual …